Blenrep’s Comeback Continues As England Becomes First To Fund Drug

 
• By Eliza Slawther
Blenrep was recently approved as a second-line treatment for multiple myeloma in combination with other drugs (Shutterstock)

More from Health Technology Assessment

More from Product Reviews